MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Physiomics wins further contracts with Bicycle Therapeutics, Merck

StockMarketWire.com

Oncology consultancy Physiomics said it had won further contracts of undisclosed value for projects with existing clients Bicycle Therapeutics and Merck.

The project with Bicycle was the eighth signed with the UK biotech company and involved population pharmacokinetic analysis of clinical data.

The project with Merck was an extension of a project previously announced for calendar year 2020, in what was now the third year of work under a master services agreement announced in November 2017.

'It is anticipated that both projects will be completed over the next four months,' Physiomics said.

At 8:58am: (LON:PYC) Physiomics PLC share price was +0.1p at 6.85p


Story provided by StockMarketWire.com